Citigroup
RDHL

Citigroup’s Redhill Biopharma RDHL Stock Holding History

Citigroup’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7K Buy
+4,378
New +$4.04K ﹤0.01% 5341
2024
Q1 		– Sell
-5
Closed -$166 – 5817
2023
Q4 		$166 Buy
+5
New +$102 ﹤0.01% 5542
2023
Q1 		– Sell
-1
Closed -$146 – 5798
2022
Q4 		$146 Hold
1
– – ﹤0.01% 5621
2022
Q3 		$1K Sell
1
-4
-80% -$3.48K ﹤0.01% 5672
2022
Q2 		$4K Buy
5
+4
+400% +$5.49K ﹤0.01% 5707
2022
Q1 		$3K Hold
1
– – ﹤0.01% 5972
2021
Q4 		$4K Sell
1
-1
-50% -$4K ﹤0.01% 5686
2021
Q3 		$11K Sell
2
-1
-33% -$6.78K ﹤0.01% 5447
2021
Q2 		$19K Buy
3
+2
+200% +$13.8K ﹤0.01% 5339
2021
Q1 		$5K Sell
1
-1
-50% -$8.39K ﹤0.01% 5902
2020
Q4 		$15K Buy
2
+1
+100% +$8.99K ﹤0.01% 6802
2020
Q3 		$8K Hold
1
– – ﹤0.01% 6773
2020
Q2 		$5K Buy
+1
New +$6.89K ﹤0.01% 7274
2016
Q1 		– Hold
0
– – – 7711
2015
Q4 		– Hold
0
– – – 7810
2015
Q2 		– Hold
0
– – – 7706
2015
Q1 		– Hold
0
– – – 7381
2014
Q2 		– Hold
0
– -$1K – 7278
2014
Q1 		– Hold
0
– – – 6885

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return

Citigroup's RDHL Position: Q2 2026 in Review

Citigroup opened a new position in Redhill Biopharma (RDHL) in Q2 2026: 4,378 shares worth $3.7K. The stake represents ﹤0.01% of the portfolio and ranks #5341 among its holdings. This is a return to the name: Citigroup previously reported a position in RDHL as recently as Q4 2023.

Citigroup first reported a position in RDHL in Q2 2020 and has held it in 13 quarters since. The position peaked at $19K in Q2 2021. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • Citigroup held 4,378 shares of Redhill Biopharma worth $3.7K as of Q2 2026.
  • Redhill Biopharma was a new Citigroup position in Q2 2026.
  • Redhill Biopharma made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5341 holding.
  • Citigroup first reported a position in Redhill Biopharma in Q2 2020 and has held it in 13 quarters since.
  • Citigroup's Redhill Biopharma position peaked at $19K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.